Claritev Corp. (CTEV)
NYSEHealth CareHealth Information ServicesSnapshot 2026-07-07
$31.79-4.13%
Close 2026-07-07 · 1-day change
Reading CTEV? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CTEV free→NYSEHealth CareHealth Information ServicesSnapshot 2026-07-07
Reading CTEV? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CTEV free→Claritev aims to improve profit and cash flow. Operating income rose from a loss of $7.6 million to a gain of $6.6 million. Revenue stayed steady near $240 million per quarter. The company plans positive free cash flow up to $10 million in 2026.
The company still loses money and cash flow is unstable. Revenue growth is weak and may not improve. Earnings misses happened in recent quarters. The turnaround may stall or fail.
The market expects about 4% revenue growth. Our fair value is near $186, reflecting cautious optimism. We see risk in cash flow and profit stability.
Breaks if: Free cash flow remains negative for full FY26
Focus on improving operating income and cash from operations to reduce net losses and negative cash flow trends.
Stated in 6 of last 6 quarters. Operating income improved from a loss of $7.6 million in 2025-Q4 to a positive $6.6 million in 2026-Q1, showing some recovery. However, cash from operations declined from $61.2 million in 2025-Q2 to negative $45.8 million in 2026-Q1, indicating mixed progress. The trajectory shows partial delivery on operating income but volatile cash flow.
Breaks if: Operating income falls below $0 in any quarter next year
Focus on improving operating income and cash from operations to reduce net losses and negative cash flow trends.
Stated in 6 of last 6 quarters. Operating income improved from a loss of $7.6 million in 2025-Q4 to a positive $6.6 million in 2026-Q1, showing some recovery. However, cash from operations declined from $61.2 million in 2025-Q2 to negative $45.8 million in 2026-Q1, indicating mixed progress. The trajectory shows partial delivery on operating income but volatile cash flow.
Breaks if: Quarterly revenue falls below $230 million next year
Maintain and grow quarterly revenue near the $240 million level to support financial stability and growth.
Stated in 6 of last 6 quarters. Revenue has remained stable around $240 million quarterly, increasing slightly from $233.5 million in 2024-Q2 to $244.7 million in 2026-Q1. This indicates a stable revenue base with limited growth, consistent with management's stated priority.
Standing thesis, reviewed periodically — not a price target or advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“Operating income was $6.6 million, improving from prior quarter loss.”
“Operating income was negative $7.6 million.”
“Operating income was $10.1 million.”
“Operating income was $16.6 million.”
“Operating income was $9.7 million.”
“Operating income was negative $41.4 million.”
“Operating income was $6.6 million, improving from prior quarter loss.”
“Operating income was negative $7.6 million.”
“Operating income was $10.1 million.”
“Operating income was $16.6 million.”
“Operating income was $9.7 million.”
“Operating income was negative $41.4 million.”
“Revenue was $244.7 million.”
“Revenue was $246.6 million.”
“Revenue was $246.0 million.”
“Revenue was $241.6 million.”
“Revenue was $231.3 million.”
“Revenue was $232.1 million.”